HDL-mediated mechanisms of protection in cardiovascular disease

Anatol Kontush1

  • 1National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitié - Salpétrière University Hospital, ICAN, 75651 Paris Cedex 13, France anatol.kontush@upmc.fr.

Insights

Low levels of high-density lipoprotein cholesterol (HDL-C) increase cardiovascular disease risk. Understanding HDL

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Low plasma levels of high-density lipoprotein cholesterol (HDL-C) are a significant risk factor for cardiovascular disease.
  • HDL particles possess diverse atheroprotective functions, including cholesterol efflux, anti-inflammatory, and antioxidant properties.
  • The relative importance of specific HDL activities in protecting the endothelium from atherosclerosis is not fully understood.

Purpose of the Study:

  • To explore the multifaceted atheroprotective activities of HDL particles.
  • To address the need for a reliable ex vivo assay to assess HDL functionality.
  • To facilitate the development of targeted HDL therapies for cardiovascular disease prevention.

Main Methods:

  • Review of existing literature on HDL particle functions and molecular mechanisms.
  • Discussion on the challenges and requirements for developing functional HDL assays.
  • Exploration of the link between HDL functionality and therapeutic interventions.

Main Results:

  • HDL exhibits a wide range of atheroprotective effects, including cholesterol efflux, anti-inflammation, and antioxidant activities.
  • Current knowledge is insufficient to determine which specific HDL functions are most critical for endothelial protection.
  • The development of a functional HDL assay is crucial for advancing HDL-based therapies.

Conclusions:

  • A comprehensive understanding of HDL's atheroprotective mechanisms is essential.
  • A validated ex vivo assay for HDL functionality is needed to guide therapeutic strategies.
  • Further research into HDL functionality will pave the way for effective HDL-targeting therapies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
723
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K